Clinical Molecular Pathology and Treatment Developments in Advanced Uveal Melanoma: State of the Art.

Abstract excerpt

Uveal melanoma (UM) is the most common intraocular cancer, with approximately 5.2 individuals per million affected annually in the United States. It represents approximately 3% of the global malignant melanoma cases, accounting for 80% of the overall noncutaneous melanomas. Clinically, it remains silent in about 30% of the cases; when symptomatic, it generally causes metamorphopsia (painless loss or distortion of...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to SF3B1 gene
• Share to Melanoma
• Share to Molecular Targeted Therapy